My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 302

    1.

    Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients.

    Scognamiglio R, Negut C, de Kreutzenberg SV, Tiengo A, Avogaro A.

    Diabetes Care. 2006 Jan;29(1):95-100.PMID: 16373903 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients.

    Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A.

    Circulation. 2005 Jul 12;112(2):179-84. Epub 2005 Jul 5.PMID: 15998667 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

    Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

    Diabetes Care. 2003 Feb;26(2):421-6.PMID: 12547873 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.

    Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.

    J Diabetes Complications. 2007 Jan-Feb;21(1):20-7.PMID: 17189870 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.

    Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.

    Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60.PMID: 14737746 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

    Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

    Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

    Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.

    Diabetes Metab Res Rev. 2007 Jul;23(5):392-9.PMID: 17211855 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

    Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, Jacober SJ.

    Diabetes Care. 2009 Mar;32(3):381-6.PMID: 19246588 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    10.

    Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy.

    Ruggenenti P, Flores C, Aros C, Ene-Iordache B, Trevisan R, Ottomano C, Remuzzi G.

    Diabetes Care. 2003 Feb;26(2):502-9.PMID: 12547889 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The addition of acarbose to insulin lispro reduces acute glycaemic responses in patients with type-2 diabetes.

    Hermanns N, Burkert A, Haak T.

    Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):310-4.PMID: 15216448 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

    Kazda C, Hülstrunk H, Helsberg K, Langer F, Forst T, Hanefeld M.

    J Diabetes Complications. 2006 May-Jun;20(3):145-52.PMID: 16632233 [PubMed - indexed for MEDLINE]Related articles

    14.

    The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.

    Galic E, Vrtovec M, Bozikov V, Schwarzenhofer M, Milicevic Z.

    Med Sci Monit. 2005 Dec;11(12):PI87-92. Epub 2005 Nov 24.PMID: 16319804 [PubMed - indexed for MEDLINE]Related articles

    15.

    Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.

    Linnebjerg H, Kothare PA, Skrivanek Z, de la Peña A, Atkins M, Ernest CS, Trautmann ME.

    Diabet Med. 2006 Mar;23(3):240-5.PMID: 16492205 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study.

    Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N.

    J Clin Endocrinol Metab. 2006 Mar;91(3):837-42. Epub 2005 Dec 20.PMID: 16368744 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.

    Malone JK, Yang H, Woodworth JR, Huang J, Campaigne BN, Halle JP, Yale JF, Grossman LD.

    Diabetes Metab. 2000 Dec;26(6):481-7.PMID: 11173719 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia.

    Beisswenger PJ, Howell SK, O'Dell RM, Wood ME, Touchette AD, Szwergold BS.

    Diabetes Care. 2001 Apr;24(4):726-32.PMID: 11315838 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

    Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

    Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.

    Guevara-Aguirre J, Guevara M, Saavedra J, Mihic M, Modi P.

    Diabetes Metab Res Rev. 2004 Nov-Dec;20(6):472-8.PMID: 15386822 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity